Posted on 3月 15, 20213/15/21
WHO Emergency Approves J&J One-shot COVID-19 Vaccine
Posted on 3月 12, 20213/12/21
FDA to Hold ODAC Meeting for Recently Withdrawn PD-1, PD-L1 Inhibitors
Posted on 3月 12, 20213/12/21
J&J Vaccine Granted Conditional Approval in Europe as Company Announces Plans to Produce Up to 3BN Shots Next Year
Posted on 3月 11, 20213/11/21
Biden Orders Additional 100 M Doses of J&J’s COVID-19 Vaccine
Posted on 3月 10, 20213/10/21
China Lays Out Path Forward for Volume-Based Procurement, Tendering
Posted on 3月 9, 20213/9/21
European Commission, EMA Pilot Launched to Challenge Centralized Authorization Procedure
Posted on 3月 9, 20213/9/21
Minnesota’s SF 990 Bill Would Promote Increased Access to Biosimilars
Posted on 3月 8, 20213/8/21
LEEM, CEPS Framework Agreement Focuses on Innovative Drugs (ASMR 1-3), Stabilizing Prices
Posted on 3月 8, 20213/8/21
NHS England, Novartis Strike ‘Landmark’ Deal for Zolgensma Access
Posted on 3月 5, 20213/5/21